News24.com | Covid-19 vaccine: Large study supports third Pfizer jab for immunocompromised

A large study looking at breakthrough infections in immunocompromised people following two doses of the Pfizer vaccine suggests that this group may benefit from a third dose.

from News24 Top Stories https://ift.tt/3Gf1PTf